Cancer incidence 1958–99 in 1711 subjects employed for at least one year with a 20 year induction latency period
| Tumour site | ICD-7 | 1958–89 | 1990–99 | Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| O | E | SIR | 95% CI | O | E | SIR | 95% CI | O | E | SIR | 95% CI | ||
| Stomach | 151 | 8 | 9.63 | 0.83 | 0.36 to 1.63 | 5 | 3.62 | 1.38 | 0.45 to 3,23 | 13 | 13.3 | 0.98 | 0.52 to 1.68 |
| Colon | 153 | 14 | 13.0 | 1.08 | 0.59 to 1.81 | 7 | 7.42 | 0.94 | 0.38 to 1.94 | 21 | 20.4 | 1.03 | 0.64 to 1.58 |
| Rectum | 154 | 11 | 9.48 | 1.16 | 0.58 to 2.07 | 4 | 4.81 | 0.83 | 0.23 to 2.13 | 15 | 14.3 | 1.05 | 0.59 to 1.73 |
| Pancreas | 157 | 8 | 5.16 | 1.55 | 0.67 to 3.05 | 2 | 2.44 | 0.82 | 0.10 to 2.96 | 10 | 7.60 | 1.32 | 0.63 to 2.42 |
| Sinonasal cavities | 160 | 1 | 0.41 | 2.44 | 0.06 to 13.6 | 0 | 0.33 | 0.00 | 0.00 to 11.2 | 1 | 0.74 | 1.35 | 0.03 to 7.53 |
| Lung | 1621 | 19 | 14.3 | 1.33 | 0.82 to 2.11 | 12 | 8.55 | 1.40 | 0.73 to 2.45 | 31 | 22.8 | 1.36 | 0.92 to 1.93 |
| Breast | 170 | 19 | 12.9 | 1.47 | 0.90 to 2.33 | 9 | 6.62 | 1.36 | 0.62 to 2.58 | 28 | 19.6 | 1.43 | 0.95 to 2.07 |
| Prostate | 177 | 29 | 22.1 | 1.31 | 0.89 to 1.90 | 26 | 15.4 | 1.69 | 1.10 to 2.47 | 55 | 37.5 | 1.47 | 1.10 to 1.91 |
| Kidney | 1800 | 5 | 5.15 | 0.97 | 0.32 to 2.27 | 1 | 2.09 | 0.48 | 0.01 to 2.67 | 6 | 7.24 | 0.83 | 0.30 to 1.80 |
| Urinary bladder | 1801, 181 | 14 | 11.2 | 1.25 | 0.68 to 2.09 | 9 | 7.63 | 1.18 | 0.54 to 2.24 | 23 | 18.8 | 1.22 | 0.77 to 1.83 |
| Soft tissue sarcoma | 197 | 5 | 1.17 | 4.27 | 1.39 to 9.97 | 1 | 0.63 | 1.59 | 0.04 to 8.84 | 6 | 1.80 | 3.33 | 1.22 to 7.26 |
| Multiple myeloma | 203 | 6 | 2.36 | 2.54 | 0.93 to 5.53 | 1 | 1.38 | 0.72 | 0.02 to 4.04 | 7 | 3.74 | 1.87 | 0.75 to 3.86 |
| Leukaemias | 204–207 | 5 | 4.46 | 1.12 | 0.36 to 2.61 | 4 | 1.33 | 3.01 | 0.82 to 7.70 | 9 | 5.80 | 1.55 | 0.71 to 2.95 |
| All sites | 140–209 | 204 | 167 | 1.22 | 1.06 to 1.40 | 109 | 94 | 1.16 | 0.95 to 1.40 | 313 | 261 | 1.20 | 1.07 to 1.34 |